Duck Hepatitis A Virus: Uncovering the Threats and Protecting Your Flock
"A deep dive into the molecular epidemiology and genetic diversity of DHAV-3 in Shandong, China, and what it means for global poultry health."
Duck virus hepatitis (DVH), caused by duck hepatitis virus (DHV), is a rapidly spreading and fatal disease, particularly affecting young ducklings. The disease results in significant economic losses to the duck industry worldwide. DHV encompasses at least three different RNA viruses, including duck hepatitis A virus (DHAV), duck astrovirus type 1 (DAstV-1), and duck astrovirus type 2 (DAstV-2).
Among these viruses, Duck Hepatitis A Virus type 3 (DHAV-3) has become increasingly common in eastern Asia, posing new challenges for disease prevention and control. Understanding the molecular evolution and genetic variations of DHAV-3 is crucial for developing effective strategies to combat its spread.
This article explores the findings of a study conducted in Shandong Province, China, from 2012 to 2014, which delved into the molecular epidemiology and genetic diversity of DHAV-3. By analyzing clinical samples and complete coding sequences, the study provides valuable insights into the virus's behavior and potential vulnerabilities.
Disease Burden and Viral Diversity
Duck viral hepatitis is an acute, highly contagious disease that primarily affects newly hatched ducklings, especially those less than 3 weeks old. Duck hepatitis A virus (DHAV) belongs to the genus Avihepatovirus in the family Picornaviridae and is among the most reported disease-causing agents associated with duck viral hepatitis. Genomic analysis of 141 full-length sequences collected globally from 1986 to 2020 identified two main genotypes, DHAV-1 and DHAV-3, with DHAV-1 divided into seven groups and DHAV-3 into five.
Vaccination and Its Limits
Live attenuated DHAV vaccines remain a primary method for inducing immune protection and controlling duck hepatitis. Previous studies have reported effectiveness against genotype-matched homologous field strains of both DHAV-1 and DHAV-3. However, sources report continuing challenges: DHAV-3 has become predominant in some settings following widespread use of DHAV-1 vaccines, and existing DHAV-3 vaccines may not completely eliminate concerns about vaccine-strain virulence or difficulty distinguishing vaccine strains from circulating strains.
From Classical Types to Genomic Classification
Duck viral hepatitis was historically subdivided into types I, II, and III. The originally described type I is caused by one of at least three DHAV genotypes, while DHAV-1 is described as the most widespread and virulent type. Later genomic and phylogenetic work established DHAV-1 and DHAV-3 as the two main genotypes and examined their diversity, geographic distribution, and recombination.
What Does the Study Reveal About DHAV-3 in Shandong?
Between January 2012 and December 2014, researchers collected liver samples from 482 dead Cherry Valley ducklings (under three weeks old) across 126 flocks in Shandong Province, China. None of these duckling flocks had been vaccinated against DVH. The mortality rate among the flocks ranged from 20% to 85%, with sick ducklings dying quickly from hemorrhagic hepatitis.
- High Detection Rate: DHAV-3 was detected in 64.5% (311/482) of clinical liver samples and 73.0% (92/126) of duckling flocks.
- Genetic Similarity: The P1 genes of the 18 DHAV-3 isolates shared 91.9%-99.0% nucleotide similarity and 95.2%-100% amino acid similarity with other reference strains.
- Geographic Distribution: Phylogenetic analysis indicated that the genotyping of DHAV-3 strains showed distinct geographical patterns.
- Genotypes: Chinese strains (excluding B63) were classified into the CH genotype. Korean and Vietnamese strains belonged to the KV genotype.
- Subgenotypes: Korean strains clustered into KV1, while B63 and Vietnamese strains clustered into KV2.
- Variable Amino Acid Residues: Ten variable amino acid residues were highly conserved within genotypes or subgenotypes in VP0, VP3, and VP1, potentially serving as geographic molecular markers.
New DHAV-3 Strains Under Investigation
Recent research has focused on DHAV-3, which is described as a major cause of viral hepatitis in ducks in Asia and as a primary cause of severe hepatitis in ducklings. In March 2026, researchers reported isolating and purifying a potentially novel DHAV-3 strain designated HNAY2024 from an immunized duck farm in Henan Province. They obtained its complete genome through whole-genome sequencing and subjected it to phylogenetic analysis, while reviews report that ducklings younger than 21 days are particularly susceptible to DHAV-3.
Unresolved Pathogenicity Questions
DHAV-3 can cause significant economic losses for duck farms in China. The available research also indicates that important questions remain about its pathogenicity and the antiviral molecular mechanisms involved. This means that identifying the virus alone does not fully resolve why disease severity varies or how ducklings respond at the molecular level.
The HB80 Vaccine Milestone
Comparative research on duck liver gene expression places vaccination within the broader effort to understand protection against DHAV-3. In China, HB80 was developed as the first officially licensed live attenuated DHAV-3 vaccine strain. The reported focus of this work is its protective efficacy against DHAV-3 infection in ducks, providing a specific benchmark for evaluating vaccine-based control.
Why This Matters: Implications for Duck Farming and Disease Control
This study contributes significantly to our understanding of DHAV-3's genetic variation and molecular epidemiology. Identifying highly conserved variable amino acid residues within genotypes or subgenotypes can pave the way for developing targeted diagnostic and control strategies. This knowledge can empower duck farmers to implement better biosecurity measures, vaccination programs, and monitoring systems, ultimately reducing economic losses and improving poultry health.
A Continuing Flock-Health Challenge
DHAV remains a serious flock-health concern because it can spread rapidly among susceptible ducklings. The available material suggests that control depends on combining vaccination with close attention to the age and vulnerability of birds. Because viral diversity and genotype changes remain important considerations, prevention strategies should be reviewed as new evidence emerges.
Improving Prevention and Surveillance
Future work will likely need to clarify how DHAV variants evolve and how well vaccines protect against different circulating strains. More precise surveillance could help identify emerging threats earlier. Research that connects genomic findings with disease severity and vaccine performance may strengthen flock-protection strategies.
Disease Control Across Duck Production
Duck hepatitis A virus illustrates how infectious disease can create challenges beyond individual birds, affecting flock management and production systems. Control may be complicated when multiple viral genotypes circulate or when protection is not equally effective across strains. Coordinated monitoring, biosecurity, and evidence-based vaccination are therefore likely to remain important.
Protecting Flocks and Livelihoods
For duck farmers, an outbreak can threaten animal welfare, production continuity, and economic stability. Practical protection depends on recognizing that young ducklings are especially vulnerable and that rapid spread can magnify losses. Clear veterinary guidance and consistent preventive management can help farmers respond to this risk.